Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label oxygen-enhanced MRI study of flutiform in moderate to severe persistent asthma
2015-000172-98Phase 4Completed
- Sponsor
- University of Leicester
- Start
- Jun 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of fluticasone propionate + formoterol, fluticasone propionate and formoterol in asthma, sponsored by University of Leicester. Primary endpoint: Change in oxygen exponential washout time and major airway ventilation time by dynamic OE-MRI. Started Jun 2019; status: completed.
02
Drugs
fluticasone propionate + formoterolfluticasone propionateformoterol
03
Conditions
asthma
Beyond the preview
Go deeper on 2015-000172-98.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-000172-98.